Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Phio Pharmaceuticals Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 15 | 12 | −3 |
| Shares | 727.7K | 575.3K | −152.4K (−20.9%) |
| Value | $415.0K | $213.2K | −$201.8K (−48.6%) |
New holders (1)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 23,029 | $8.52K | 0.00% |
Sold out (4)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Virtu Financial LLC | 19,464 | $11.0K |
| HRT Financial LP | 18,280 | $10.0K |
| Ergoteles LLC | 12,471 | $7.00K |
| Balyasny Asset Management LLC | 10,036 | $6.00K |